Pacific Biosciences of California, Inc. Payments to Acquire Investments
Pacific Biosciences of California, Inc. (PACB) reported Payments to Acquire Investments of $57.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-06
- Pacific Biosciences of California, Inc. payments to acquire investments for the quarter ending 2026-06-30 was $5.10M, a 90.92% decline year-over-year.
- Pacific Biosciences of California, Inc. payments to acquire investments for the quarter ending 2026-03-31 was $52.45M, a 15.16% decline year-over-year.
- Pacific Biosciences of California, Inc. payments to acquire investments for the quarter ending 2025-12-31 was $33.09M, a 58.87% decline year-over-year.
- Pacific Biosciences of California, Inc. payments to acquire investments for the quarter ending 2025-09-30 was $65.83M, a 42.56% decline year-over-year.
- Pacific Biosciences of California, Inc. payments to acquire investments for fiscal 2025 was $216.91M, a 56.50% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. payments to acquire investments for fiscal 2024 was $498.63M, a 34.09% decline from fiscal 2023.
- Pacific Biosciences of California, Inc. payments to acquire investments for fiscal 2023 was $756.57M, a 70.86% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. payments to acquire investments for fiscal 2022 was $442.79M, a 55.19% decline from fiscal 2021.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $57.55M 10-Q · filed 2026-08-06 | $90.64M derived: sum of 3 quarters · filed 2026-08-06 | $156.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $52.45M 10-Q · filed 2026-05-08 | $85.54M derived: sum of 2 quarters · filed 2026-05-08 | $151.37M derived: sum of 3 quarters · filed 2026-05-08 | $207.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $33.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $98.92M derived: sum of 2 quarters · filed 2026-02-25 | $155.09M derived: sum of 3 quarters · filed 2026-08-06 | $216.91M 10-K · filed 2026-02-25 |
| 2025-09-30 | $65.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $122.00M derived: sum of 2 quarters · filed 2026-08-06 | $183.82M 10-Q · filed 2025-11-06 | $264.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $56.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $117.99M 10-Q · filed 2026-08-06 | $198.46M derived: sum of 3 quarters · filed 2026-08-06 | $313.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $61.82M 10-Q · filed 2026-05-08 | $142.29M derived: sum of 2 quarters · filed 2026-05-08 | $256.89M derived: sum of 3 quarters · filed 2026-05-08 | $368.55M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $80.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $195.07M derived: sum of 2 quarters · filed 2026-02-25 | $306.73M derived: sum of 3 quarters · filed 2026-02-25 | $498.63M 10-K · filed 2026-02-25 |
| 2024-09-30 | $114.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $226.26M derived: sum of 2 quarters · filed 2025-11-06 | $418.16M 10-Q · filed 2025-11-06 | $620.98M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $111.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $303.56M 10-Q · filed 2025-08-07 | $506.38M derived: sum of 3 quarters · filed 2026-02-25 | $583.25M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $191.91M 10-Q · filed 2025-05-12 | $394.73M derived: sum of 2 quarters · filed 2026-02-25 | $471.60M derived: sum of 3 quarters · filed 2026-02-25 | $715.18M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $202.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $279.69M derived: sum of 2 quarters · filed 2026-02-25 | $523.28M derived: sum of 3 quarters · filed 2026-02-25 | $756.57M 10-K · filed 2026-02-25 |
| 2023-09-30 | $76.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $320.46M derived: sum of 2 quarters · filed 2024-11-12 | $553.75M 10-Q · filed 2024-11-12 | $688.64M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $243.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $476.88M 10-Q · filed 2024-08-09 | $611.77M derived: sum of 3 quarters · filed 2025-03-17 | $678.58M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $233.29M 10-Q · filed 2024-05-09 | $368.18M derived: sum of 2 quarters · filed 2025-03-17 | $434.99M derived: sum of 3 quarters · filed 2025-03-17 | $599.71M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $134.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $201.70M derived: sum of 2 quarters · filed 2025-03-17 | $366.42M derived: sum of 3 quarters · filed 2025-03-17 | $442.79M 10-K · filed 2025-03-17 |
| 2022-09-30 | $66.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $231.53M derived: sum of 2 quarters · filed 2023-11-03 | $307.90M 10-Q · filed 2023-11-03 | $438.52M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $164.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $241.09M 10-Q · filed 2023-08-04 | $371.71M derived: sum of 3 quarters · filed 2024-02-28 | $593.73M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $76.37M 10-Q · filed 2023-05-04 | $206.99M derived: sum of 2 quarters · filed 2024-02-28 | $429.01M derived: sum of 3 quarters · filed 2024-02-28 | $999.99M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $130.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $352.65M derived: sum of 2 quarters · filed 2024-02-28 | $923.62M derived: sum of 3 quarters · filed 2024-02-28 | $988.05M 10-K · filed 2024-02-28 |
| 2021-09-30 | $222.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $793.00M derived: sum of 2 quarters · filed 2022-11-08 | $857.42M 10-Q · filed 2022-11-08 | $996.15M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $570.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $635.40M 10-Q · filed 2022-08-08 | $774.13M derived: sum of 3 quarters · filed 2023-02-28 | $889.48M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $64.43M 10-Q · filed 2022-05-06 | $203.15M derived: sum of 2 quarters · filed 2023-02-28 | $318.51M derived: sum of 3 quarters · filed 2023-02-28 | $364.75M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $138.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $254.08M derived: sum of 2 quarters · filed 2023-02-28 | $300.32M derived: sum of 3 quarters · filed 2023-02-28 | $373.28M 10-K · filed 2023-02-28 |
| 2020-09-30 | $115.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $161.59M derived: sum of 2 quarters · filed 2021-11-05 | $234.56M 10-Q · filed 2021-11-05 | $249.57M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $46.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $119.20M 10-Q · filed 2021-08-06 | $134.22M derived: sum of 3 quarters · filed 2022-02-28 | $140.18M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $72.96M 10-Q · filed 2021-05-06 | $87.98M derived: sum of 2 quarters · filed 2022-02-28 | $93.94M derived: sum of 3 quarters · filed 2022-02-28 | $113.06M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $15.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $20.98M derived: sum of 2 quarters · filed 2022-02-28 | $40.10M derived: sum of 3 quarters · filed 2022-02-28 | $57.73M 10-K · filed 2022-02-28 |
| 2019-09-30 | $5.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $25.09M derived: sum of 2 quarters · filed 2020-11-03 | $42.71M 10-Q · filed 2020-11-03 | $60.66M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $19.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $36.75M 10-Q · filed 2020-08-06 | $54.70M derived: sum of 3 quarters · filed 2021-02-26 | $114.43M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $17.62M 10-Q · filed 2020-05-08 | $35.58M derived: sum of 2 quarters · filed 2021-02-26 | $95.31M derived: sum of 3 quarters · filed 2021-02-26 | $108.26M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $17.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $77.68M derived: sum of 2 quarters · filed 2021-02-26 | $90.64M derived: sum of 3 quarters · filed 2021-02-26 | $122.18M 10-K · filed 2021-02-26 |
| 2018-09-30 | $59.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $72.68M derived: sum of 2 quarters · filed 2019-11-07 | $104.23M 10-Q · filed 2019-11-07 | $115.98M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $12.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $44.50M 10-Q · filed 2019-08-06 | $56.25M derived: sum of 3 quarters · filed 2020-02-28 | $69.66M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $31.55M 10-Q · filed 2019-05-03 | $43.30M derived: sum of 2 quarters · filed 2020-02-28 | $56.70M derived: sum of 3 quarters · filed 2020-02-28 | $107.47M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $11.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $25.16M derived: sum of 2 quarters · filed 2020-02-28 | $75.92M derived: sum of 3 quarters · filed 2020-02-28 | $86.34M 10-K · filed 2020-02-28 |
| 2017-09-30 | $13.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $64.17M derived: sum of 2 quarters · filed 2018-11-05 | $74.59M 10-Q · filed 2018-11-05 | $88.41M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $50.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $61.18M 10-Q · filed 2018-08-03 | $75.00M derived: sum of 3 quarters · filed 2019-02-26 | $92.46M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $10.42M 10-Q · filed 2018-05-02 | $24.24M derived: sum of 2 quarters · filed 2019-02-26 | $41.70M derived: sum of 3 quarters · filed 2019-02-26 | $62.88M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $13.82M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $31.28M derived: sum of 2 quarters · filed 2019-02-26 | $52.47M derived: sum of 3 quarters · filed 2019-02-26 | $95.85M 10-K · filed 2019-02-26 |
| 2016-09-30 | $17.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $38.65M derived: sum of 2 quarters · filed 2017-11-02 | $82.03M 10-Q · filed 2017-11-02 | $122.89M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $21.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $64.57M 10-Q · filed 2017-08-02 | $105.44M derived: sum of 3 quarters · filed 2018-02-26 | $108.57M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $43.38M 10-Q · filed 2017-05-05 | $84.25M derived: sum of 2 quarters · filed 2018-02-26 | $87.38M derived: sum of 3 quarters · filed 2018-02-26 | $102.70M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $40.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $44.00M derived: sum of 2 quarters · filed 2018-02-26 | $59.31M derived: sum of 3 quarters · filed 2018-02-26 | $84.58M 10-K · filed 2018-02-26 |
| 2015-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $18.45M derived: sum of 2 quarters · filed 2016-11-04 | $43.72M 10-Q · filed 2016-11-04 | $72.66M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $15.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $40.58M 10-Q · filed 2016-08-04 | $69.53M derived: sum of 3 quarters · filed 2017-03-06 | $100.12M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $25.27M 10-Q · filed 2016-05-05 | $54.21M derived: sum of 2 quarters · filed 2017-03-06 | $84.80M derived: sum of 3 quarters · filed 2017-03-06 | $115.16M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $28.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $59.54M derived: sum of 2 quarters · filed 2017-03-06 | $89.90M derived: sum of 3 quarters · filed 2017-03-06 | $126.41M 10-K · filed 2017-03-06 |
| 2014-09-30 | $30.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $60.95M derived: sum of 2 quarters · filed 2015-11-05 | $97.47M 10-Q · filed 2015-11-05 | $157.47M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $30.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $66.88M 10-Q · filed 2015-08-05 | $126.87M derived: sum of 3 quarters · filed 2016-03-11 | $156.90M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $36.52M 10-Q · filed 2015-05-05 | $96.51M derived: sum of 2 quarters · filed 2016-03-11 | $126.54M derived: sum of 3 quarters · filed 2016-03-11 | $195.60M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $90.02M derived: sum of 2 quarters · filed 2016-03-11 | $159.08M derived: sum of 3 quarters · filed 2016-03-11 | $201.55M 10-K · filed 2016-03-11 |
| 2013-09-30 | $30.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $99.08M derived: sum of 2 quarters · filed 2014-11-05 | $141.55M 10-Q · filed 2014-11-05 | $160.00M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $69.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $111.52M 10-Q · filed 2014-08-05 | $129.98M derived: sum of 3 quarters · filed 2015-03-12 | $145.05M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $42.47M 10-Q · filed 2014-05-08 | $60.92M derived: sum of 2 quarters · filed 2015-03-12 | $76.00M derived: sum of 3 quarters · filed 2015-03-12 | $110.22M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $18.45M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $33.53M derived: sum of 2 quarters · filed 2015-03-12 | $67.75M derived: sum of 3 quarters · filed 2015-03-12 | $87.89M 10-K · filed 2015-03-12 |
| 2012-09-30 | $15.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $49.30M derived: sum of 2 quarters · filed 2013-11-12 | $69.44M 10-Q · filed 2013-11-12 | $100.55M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $34.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $54.36M 10-Q · filed 2013-08-09 | $85.47M derived: sum of 3 quarters · filed 2014-03-14 | $129.78M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $20.14M 10-Q · filed 2013-05-10 | $51.25M derived: sum of 2 quarters · filed 2014-03-14 | $95.56M derived: sum of 3 quarters · filed 2014-03-14 | $152.99M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $31.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $75.42M derived: sum of 2 quarters · filed 2014-03-14 | $132.85M derived: sum of 3 quarters · filed 2014-03-14 | $264.07M 10-K · filed 2014-03-14 |
| 2011-09-30 | $44.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $101.74M derived: sum of 2 quarters · filed 2012-11-01 | $232.96M 10-Q · filed 2012-11-01 | $337.61M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $57.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $188.65M 10-Q · filed 2012-08-07 | $293.30M derived: sum of 3 quarters · filed 2013-03-15 | $320.88M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $131.22M 10-Q · filed 2012-05-07 | $235.87M derived: sum of 2 quarters · filed 2013-03-15 | $263.45M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | $104.65M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $132.23M derived: sum of 2 quarters · filed 2013-03-15 | $180.96M 10-K · filed 2013-03-15 | |
| 2010-09-30 | $27.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $76.31M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $48.73M 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $25.43M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |